Analogic’s new multipurpose SyneRad OMNI DR digital radiography system is debuting this week at RSNA 2004. The system received FDA 510(k) clearance just last week.
Analogic's new multipurpose SyneRad OMNI DR digital radiography system is debuting this week at RSNA 2004. The system received FDA 510(k) clearance just last week.
SyneRad features the company's new GR17 amorphous selenium flat-panel detector, which was developed by Analogic's Canadian subsidiary Anrad. Analogic designs and manufactures advanced health and security systems.
The new system is being sold by Anexa, another Analogic subsidiary that sells digital imaging products directly to end-users in select U.S. markets.
"We've designed the SyneRad OMNI to meet the clinical demands of our emergency medicine and orthopedic office customers," said John Ross, vice president of marketing for Anexa.
The SyneRad OMNI provides multiframe acquisition in 17 x 17-inch fields, providing expanded clinical utility in joint stability and motion studies.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.